Issue 1277: November 30, 2016
Ask the Experts—Question of the Week: Why are zoster, pneumococcal polysaccharide (PPSV23) and meningococcal…read more
FDA approves extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On November 18, the U.S. Food and Drug Administration (FDA) approved an expanded age indication for FluLaval Quadrivalent (GSK). FluLaval Quadrivalent is now also licensed for use in children 6 to 35 months of age. Previously, it was licensed for patients age 3 years and older.
November Current Issues in Vaccines
webinar presented by Dr. Paul Offit archived on VEC’s website; CE available
CDC and WHO report on progress toward polio eradication in Pakistan in this week's MMWR and Weekly Epidemiological Report, respectively
National Meningitis Association releases #Pledge2Prevent toolkit
The National Meningitis Association (NMA) released its #Pledge2Prevent toolkit to help student groups advocate for increased meningococcal disease awareness and vaccination mandates at universities across the country. The kit includes a variety of resources, including sample op-eds, petitions, and templates for writing university administrators.
Influenza is spreading and serious; please keep vaccinating your patients
Influenza vaccination is recommended for everyone six months of age and older. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services.
JOURNAL ARTICLES AND NEWSLETTERS
Vaccine Education Center's newsletter for healthcare professionals includes a review of MenB vaccine in infants research, an article reviewing serological testing recommendations pre- and post-hepatitis B vaccination, and information on 2-dose versus 3-dose HPV schedules
The Vaccine Education Center (VEC) at the Children's Hospital of Philadelphia publishes a monthly immunization-focused newsletter titled Vaccine Update for Healthcare Professionals. The November issue includes the following articles:
ASK THE EXPERTS
Question of the Week
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
Editor-in-ChiefKelly L. Moore, MD, MPH
Managing EditorJohn D. Grabenstein, RPh, PhD
Associate EditorSharon G. Humiston, MD, MPH
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA
Style and Copy EditorMarian Deegan, JD
Web Edition ManagersArkady Shakhnovich
Contributing WriterLaurel H. Wood, MPA
Technical ReviewerKayla Ohlde